2015
DOI: 10.1016/j.jacl.2015.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Primary hypertriglyceridemia in children and adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
70
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 67 publications
(71 citation statements)
references
References 61 publications
0
70
0
1
Order By: Relevance
“…Regarding pharmacological management, there are no FDA-approved TG level-lowering medications for use under 18 years of age, and there are no established indications for their use in children [7,19]. Nevertheless, extrapolation of adult guidelines may be judiciously applied in this scenario [7,8,13].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Regarding pharmacological management, there are no FDA-approved TG level-lowering medications for use under 18 years of age, and there are no established indications for their use in children [7,19]. Nevertheless, extrapolation of adult guidelines may be judiciously applied in this scenario [7,8,13].…”
Section: Discussionmentioning
confidence: 99%
“…A TG level greater than or equal to 100 mg/dL for children of ages 0 to 9 years and a level greater than or equal to 130 mg/dL for children of ages 10 to 19 years are considered above the 95 th percentile [3][4][5][6]. Hypertriglyceridemia can be classified as mild to borderline high (150-199 mg/dL), moderate to high (200-499 mg/dL), very high (500-999 mg/dL), severe (1000-1999 mg/dL) and very severe (> 2000 mg/ dL) [5,7,8].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Hypertriglyceridaemia presenting in the neonatal period is most commonly due to mutations in the LPL gene, which results in elevated levels of chylomicrons, while a number of other genes may be involved in genetic hypertriglyceridaemia presenting in adulthood, including APOE 6. While hypertriglyceridaemia presenting in the neonatal period is most commonly primary (genetic), the differential diagnosis of hypertriglyceridaemia in children and adolescents includes secondary causes such as hypothyroidism, obesity and the metabolic syndrome, cholestasis, nephrotic syndrome, glycogen storage disease type 1, poorly controlled diabetes and medications such as oral retinoids, the contraceptive pill and atypical antipsychotics 6 7…”
Section: Differential Diagnosismentioning
confidence: 99%
“…While hypertriglyceridaemia presenting in the neonatal period is most commonly primary (genetic), the differential diagnosis of hypertriglyceridaemia in children and adolescents includes secondary causes such as hypothyroidism, obesity and the metabolic syndrome, cholestasis, nephrotic syndrome, glycogen storage disease type 1, poorly controlled diabetes and medications such as oral retinoids, the contraceptive pill and atypical antipsychotics 6 7…”
Section: Differential Diagnosismentioning
confidence: 99%